Table 3.
Outcomes of patients according to body composition and sex
| SAT index | SM index | ||||||
|---|---|---|---|---|---|---|---|
| Low (%)a | High (%)b | Low (%)b | High (%)2 | Male (%) | Female (%) | Overall (%) | |
| Metastasis‐free survival | |||||||
| 5 years | 79.2 | 86.7 | 81.3 | 84.6 | 81.3 | 91.1 | 83.0 |
| 10 years | 77.7 | 86.3 | 80.9 | 83.4 | 80.0 | 91.1 | 82.1 |
| Locoregional control | |||||||
| 5 years | 69.0 | 77.3 | 68.7 | 77.5 | 70.8 | 84.6 | 73.4 |
| 10 years | 66.8 | 75.6 | 66.8 | 75.6 | 68.9 | 82.6 | 71.4 |
| Overall survival | |||||||
| 5 years | 60.3 | 72.2 | 59.2 | 73.2 | 62.8 | 83.0 | 66.4 |
| 10 years | 48.5 | 66.7 | 50.2 | 64.8 | 53.3 | 77.6 | 57.6 |
SAT, subcutaneous fat tissue; SM, skeletal muscle.
a
Low SAT defined as SAT index <19.49 cm2/m2 for women and <7.24 cm2/m2 for men, high SAT defined as SAT index ≥ 19.49 cm2/m2 for women and ≥7.24 cm2/m2 for men.
b
Low SM defined as SM index <34.3 cm2/m2 for women and < 51.74 cm2/m2 for men, high SM defined as SM index ≥ 34.3 cm2/m2 for women and ≥ 51.74 cm2/m2 for men.